Deferred Tax Assets, Net of Valuation Allowance of LIFECORE BIOMEDICAL, INC. \DE\ from 27 May 2012 to 25 May 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: LIFECORE BIOMEDICAL, INC. \DE\ quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 27 May 2012 to 25 May 2025.
LIFECORE BIOMEDICAL, INC. \DE\ Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 25 May 2025 was $18,757,000, a 9.1% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$18,757,000	-$1,884,000	-9.1%	25 May 2025	10-K	07 Aug 2025	2025	FY
Q2 2024	$20,641,000	+$6,786,000	+49%	26 May 2024	10-K	07 Aug 2025	2025	FY
Q2 2023	$13,855,000			28 May 2023	10-K	26 Aug 2024	2024	FY
Q2 2019	$12,678,000	+$6,933,000	+121%	26 May 2019	10-K	01 Aug 2019	2019	FY
Q2 2018	$5,745,000	-$2,681,000	-32%	27 May 2018	10-K	01 Aug 2019	2019	FY
Q2 2017	$8,426,000	+$1,970,000	+31%	28 May 2017	10-K	09 Aug 2018	2018	FY
Q2 2016	$6,456,000	+$168,000	+2.7%	29 May 2016	10-K/A	15 Mar 2018	2017	FY
Q2 2015	$6,288,000	+$30,000	+0.48%	31 May 2015	10-K	01 Aug 2016	2016	FY
Q2 2014	$6,258,000	+$243,000	+4%	25 May 2014	10-K	31 Jul 2015	2015	FY
Q2 2013	$6,015,000	-$1,448,000	-19%	26 May 2013	10-K	01 Aug 2014	2014	FY
Q2 2012	$7,463,000			27 May 2012	10-K	07 Aug 2013	2013	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.